Physician

Nitasha Kumar, M.D.

According to 2025 Medicare claims, Nitasha Kumar, M.D. (NPI: 1093135113) practices rheumatology in the Frederick-Gaithersburg-Bethesda, MD market, with the plurality of this provider's patient population coming from Montgomery, MD. This provider's primary affiliated billing organization is ARTHRITIS AND RHEUMATISM ASSOCIATES PC (NPI: 1447259866; TIN: 521072944) and primary practice location at 20850-8727.

Kumar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,557 traditional Medicare patients, billed 137,351 HCPCS/CPT codes, and received $2,031,036 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,105 prescription claims across 387 beneficiaries totaling $1,486,859 in drug costs, led by Enbrel Sureclick (Etanercept). DME data shows 12 claims. Open Payments data shows 1 records totaling $36. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,438,864 and ending at $2,031,036. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $17,742 to $1,486,859. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	668	74,537	$1,438,864
2021	850	86,248	$1,519,347
2022	1,323	132,978	$2,453,730
2023	1,394	90,862	$1,564,267
2024	1,557	137,351	$2,031,036

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	11	$17,742
2020	115	445	$49,765
2021	140	614	$82,030
2022	239	1,089	$342,245
2023	314	1,726	$1,002,189
2024	387	2,105	$1,486,859

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	12	$768

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	502	932	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	561	704	$74
77080	Dxa bone density measurement of hip, pelvis, spine	690	690	$44
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	849	1,544	$13
36415	Insertion of needle into vein for collection of blood sample	435	654	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	29	1,594	$415,267
Cosentyx Sensoready Pen	Secukinumab	16	734	$167,172
Humira(Cf) Pen	Adalimumab	21	644	$163,631
Actemra Actpen	Tocilizumab	15	980	$112,242
Enbrel	Etanercept	11	320	$89,633

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	12	$768

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$36	Pacira Pharmaceuticals Incorporated
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nitasha Kumar, M.D.?

Tedicare shows public-source Medicare data for Nitasha Kumar, M.D. (NPI 1093135113), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nitasha Kumar, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nitasha Kumar, M.D.?

Nitasha Kumar, M.D. is linked to ARTHRITIS AND RHEUMATISM ASSOCIATES PC (billing NPI 1447259866) in the available physician profile data.

Does Nitasha Kumar, M.D. have Open Payments data?

Nitasha Kumar, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.